PETV — PetVivo Holdings Share Price
- $12.83m
- $14.12m
- $0.97m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 13.42 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -4900.38% | ||
Return on Equity | -8749.74% | ||
Operating Margin | -902.11% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 0 | 0.01 | 0.12 | 0.92 | 0.97 | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use. Spryng with OsteoCushion Technology, its flagship product, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. It also has a pipeline that includes several therapeutic devices for both veterinary and human clinical applications. The Company manufactures its products in an ISO 7 certified clean room manufacturing facility in Minneapolis using its patented and scalable self-assembly production process. The Company may establish strategic out-licensing partnerships.
Directors
- Gregory Cash CHM (61)
- John Lai PRE (56)
- Robert Folkes CFO (57)
- Randall Meyer COO (57)
- Randy Wenthold CSO
- John Dolan GCN (56)
- David Masters OTH
- Sherry Grisewood DRC
- Joseph Jasper DRC
- David Merrill DRC (69)
- Robert Rudelius DRC (64)
- David Deming IND (61)
- Peter Vezmar IND (58)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 31st, 2009
- Public Since
- July 10th, 2012
- No. of Shareholders
- 320
- No. of Employees
- 20
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 23,559,750

- Address
- 5251 Edina Industrial Blvd, EDINA, 55439
- Web
- https://petvivo.com/
- Phone
- +1 9522174952
- Auditors
- Assurance Dimensions
Upcoming Events for PETV
Q1 2026 PetVivo Holdings Inc Earnings Release
Q1 2026 PetVivo Holdings Inc Earnings Release
Similar to PETV
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 04:37 UTC, shares in PetVivo Holdings are trading at $0.54. This share price information is delayed by 15 minutes.
Shares in PetVivo Holdings last closed at $0.54 and the price had moved by -31.93% over the past 365 days. In terms of relative price strength the PetVivo Holdings share price has underperformed the S&P500 Index by -36.41% over the past year.
The overall consensus recommendation for PetVivo Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out morePetVivo Holdings does not currently pay a dividend.
PetVivo Holdings does not currently pay a dividend.
PetVivo Holdings does not currently pay a dividend.
To buy shares in PetVivo Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.54, shares in PetVivo Holdings had a market capitalisation of $12.83m.
Here are the trading details for PetVivo Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PETV
Based on an overall assessment of its quality, value and momentum PetVivo Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in PetVivo Holdings is $7.00. That is 1185.52% above the last closing price of $0.54.
Analysts covering PetVivo Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like PetVivo Holdings. Over the past six months, its share price has outperformed the S&P500 Index by +12.51%.
As of the last closing price of $0.54, shares in PetVivo Holdings were trading -6.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The PetVivo Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.54.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
PetVivo Holdings' management team is headed by:
- Gregory Cash - CHM
- John Lai - PRE
- Robert Folkes - CFO
- Randall Meyer - COO
- Randy Wenthold - CSO
- John Dolan - GCN
- David Masters - OTH
- Sherry Grisewood - DRC
- Joseph Jasper - DRC
- David Merrill - DRC
- Robert Rudelius - DRC
- David Deming - IND
- Peter Vezmar - IND